KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Edgewell Personal Care (EPC) Research & Development (2016 - 2026)

Edgewell Personal Care has reported Research & Development over the past 17 years, most recently at $13.8 million for Q4 2025.

  • Quarterly Research & Development rose 2.99% to $13.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $57.5 million through Dec 2025, down 1.71% year-over-year, with the annual reading at $57.6 million for FY2025, 1.37% down from the prior year.
  • Research & Development was $13.8 million for Q4 2025 at Edgewell Personal Care, down from $15.8 million in the prior quarter.
  • Over five years, Research & Development peaked at $16.3 million in Q3 2024 and troughed at $12.8 million in Q4 2021.
  • The 5-year median for Research & Development is $14.2 million (2021), against an average of $14.4 million.
  • Year-over-year, Research & Development grew 17.74% in 2021 and then decreased 6.85% in 2022.
  • A 5-year view of Research & Development shows it stood at $12.8 million in 2021, then rose by 4.69% to $13.4 million in 2022, then dropped by 0.75% to $13.3 million in 2023, then grew by 0.75% to $13.4 million in 2024, then grew by 2.99% to $13.8 million in 2025.
  • Per Business Quant, the three most recent readings for EPC's Research & Development are $13.8 million (Q4 2025), $15.8 million (Q3 2025), and $14.0 million (Q2 2025).